Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Working Capital/Sales

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 2.542.521.691.66

What is the latest Working Capital/Sales ratio of CONCORD BIOTECH ?

The latest Working Capital/Sales ratio of CONCORD BIOTECH is 2.54 based on Mar2023 Consolidated results.
Year Working Capital/Sales
Mar20232.54
Mar20222.52
Mar20211.69
Mar20201.66

How is Working Capital/Sales of CONCORD BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2023 2.54
0.79
Mar2022 2.52
49.11
Mar2021 1.69
1.81
Mar2020 1.66 -

Other Financial Ratios of CONCORD BIOTECH


Compare Working Capital/Sales ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹14,973.5 Cr -0.4% -5.3% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹112,990.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1% -2.4% 28.4% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-0.4%

-5.3%

NA
SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses